The interaction between recombinant OFD1 and E2F4 was further validated by endogenous immunoprecipitation (IP) in three pancreatic cancer cell lines (Fig. 6e) and an in vitro pulldown assay (Supplementary Fig. 6i,,  j). The gene discussed is E2F4; the disease is pancreatic neoplasm.